BVXV Annual Operating Expenses
$11.06 M
+$199.00 K+1.83%
31 December 2022
Summary:
As of February 5, 2025, BVXV annual total operating expenses is $11.06 million, with the most recent change of +$199.00 thousand (+1.83%) on December 31, 2022. During the last 3 years, it has fallen by -$11.57 million (-51.11%).BVXV Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Quarterly Operating Expenses
$2.60 M
-$591.00 K-18.55%
30 June 2023
Summary:
As of February 5, 2025, BVXV quarterly total operating expenses is $2.60 million, with the most recent change of -$591.00 thousand (-18.55%) on June 30, 2023. Over the past year, it has dropped by -$668.00 thousand (-20.47%).BVXV Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BVXV Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +1.8% | -20.5% |
| 3 y3 years | -51.1% | -44.4% |
| 5 y5 years | +62.5% | -69.0% |
BVXV Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -51.1% | -72.6% |
BiondVax Pharmaceuticals Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $2.60 M(-18.5%) |
| Mar 2023 | - | $3.19 M(-53.1%) |
| Dec 2022 | $11.06 M(+1.8%) | $6.80 M(-726.4%) |
| Sept 2022 | - | -$1.08 M(-133.3%) |
| June 2022 | - | $3.26 M(+24.8%) |
| Mar 2022 | - | $2.62 M(-24.1%) |
| Dec 2021 | $10.86 M(-576.2%) | $3.44 M(+34.8%) |
| Sept 2021 | - | $2.55 M(-6.6%) |
| June 2021 | - | $2.73 M(+35.2%) |
| Mar 2021 | - | $2.02 M(-39.9%) |
| Dec 2020 | -$2.28 M(-110.1%) | $3.36 M(-120.9%) |
| Sept 2020 | - | -$16.12 M(-445.5%) |
| June 2020 | - | $4.67 M(-16.9%) |
| Mar 2020 | - | $5.62 M(-40.8%) |
| Dec 2019 | $22.63 M(+10.6%) | $9.48 M(+74.6%) |
| Sept 2019 | - | $5.43 M(-1.4%) |
| June 2019 | - | $5.51 M(+179.0%) |
| Mar 2019 | - | $1.97 M(-71.3%) |
| Dec 2018 | $20.46 M | $6.87 M(+326.4%) |
| Sept 2018 | - | $1.61 M(-80.8%) |
| June 2018 | - | $8.38 M(+133.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $3.60 M(-16.8%) |
| Dec 2017 | $6.81 M(+120.0%) | $4.32 M(+375.3%) |
| Sept 2017 | - | $909.40 K(+22.4%) |
| June 2017 | - | $742.90 K(-9.3%) |
| Mar 2017 | - | $819.10 K(+8.5%) |
| Dec 2016 | $3.09 M(+6.8%) | $754.80 K(-18.3%) |
| Sept 2016 | - | $924.20 K(+43.9%) |
| June 2016 | - | $642.40 K(-14.3%) |
| Mar 2016 | - | $749.60 K(-28.7%) |
| Dec 2015 | $2.90 M(+38.5%) | $1.05 M(+86.6%) |
| Sept 2015 | - | $563.20 K(-33.7%) |
| June 2015 | - | $850.10 K(+84.6%) |
| Mar 2015 | - | $460.50 K(+9.9%) |
| Dec 2014 | $2.09 M(-4.7%) | $419.00 K(-21.2%) |
| Sept 2014 | - | $531.80 K(-16.3%) |
| June 2014 | - | $635.60 K(+10.2%) |
| Mar 2014 | - | $576.90 K(+2.7%) |
| Dec 2013 | $2.19 M(-10.3%) | $561.50 K(+3.2%) |
| Sept 2013 | - | $544.00 K |
| Dec 2012 | $2.44 M(+13.1%) | - |
| Dec 2011 | $2.16 M | - |
FAQ
- What is BiondVax Pharmaceuticals annual total operating expenses?
- What is the all time high annual operating expenses for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals annual operating expenses year-on-year change?
- What is BiondVax Pharmaceuticals quarterly total operating expenses?
- What is the all time high quarterly operating expenses for BiondVax Pharmaceuticals?
- What is BiondVax Pharmaceuticals quarterly operating expenses year-on-year change?
What is BiondVax Pharmaceuticals annual total operating expenses?
The current annual operating expenses of BVXV is $11.06 M
What is the all time high annual operating expenses for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high annual total operating expenses is $22.63 M
What is BiondVax Pharmaceuticals annual operating expenses year-on-year change?
Over the past year, BVXV annual total operating expenses has changed by +$199.00 K (+1.83%)
What is BiondVax Pharmaceuticals quarterly total operating expenses?
The current quarterly operating expenses of BVXV is $2.60 M
What is the all time high quarterly operating expenses for BiondVax Pharmaceuticals?
BiondVax Pharmaceuticals all-time high quarterly total operating expenses is $9.48 M
What is BiondVax Pharmaceuticals quarterly operating expenses year-on-year change?
Over the past year, BVXV quarterly total operating expenses has changed by -$668.00 K (-20.47%)